The International Society of Anti-Infective Pharmacology is an interdisciplinary scientific society for the study of pharmacodynamics and pharmacokinetics and for the improvement of dosing of anti-infectives.

The Society efforts are focused on expanding basic and applied knowledge in this area of chemotherapeutics through the organization of symposiadiscussion workshops , and educational workshops with international participation, in connection with major scientific meetings dealing with the chemotherapy of infectious diseases (ICAAC, ICC, ECCMID ...), and other scientific societies with common interests, and Regulatory Authorities (FDA, EMA).
 

Important note:

- Opportunity for Young Investigator!
- View the presentations of the Polymyxin conference in Prato, Italy, May 2013
- The new book Fundamentals of Antimicrobial Pharmacokinetics and Pharamacodynamics is now officially published.
- Newsletter of the European PK/PD study group
ESCMID conference


Meetings 2014

 

  • The annual meeting and post-ICAAC symposium will take place on September 9th, 2014 in Washington DC
    • PK/PD special topic:
      PK/PD in the regulatory environment    
    • Forum for Young investigators: Brief presentations on PK/PD topics related to old and new anti-infectives
    See Annual meeting for more information

Workshop at ECCMID 2014

  • May 10th, 2014, Barcelona, Spain
    Basic concepts of pharmacokinetics and pharmacodynamics
    Basic concepts of PK/PD (J. Mouton)
    Translating PK/PD concepts into dosing strategies (W. Craig)
    Optimising therapy in obese and frail patients (H. Derendorf)
    Optimising therapy to minimise emergence of resistance (U. Theuretzbacher)

Sessions at ECCMID 2014

  • The Good, the Bad and the Ugly: recently approved and developmental anti-bacterials
    Developmental beta-lactamase inhibitors in phase 2/3 clinical trials (U. Theuretzbacher)
    Ceftaroline (MJ Rybak)
    Fidaxomicin (M Llewelyn)
    Tigecycline (D Plachouras)
  • PK/PD - the merits of models and measurement
    Pre-clinical in vitro models (KE Bowker)
    Pre-clinical in vivo models (N Frimodt-Moller)
    Measurement of beta-lactams in serum (F Pea)
    Value of the measurement of antibiotic concentration in tissues (JW Mouton)
  • Poster sessions
    Saturday, May 10th: PK/PD to improve treatment of critically ill patients
    Tuesday, May 13th: PK/PD of antibiotics against Gram-positives
    Tuesday, May 13th: PK/PD of antifungals and miscellaneous antibacterials
  • Altered drug disposition in the elderly
    W Couet, Poitiers, France
    L Pagani, Geneva, Switzerland